| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.4 | 8e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |